HomeAI · summaries
Storia in 13 fonti
Trump’s 200% generic tariff threat would imperil Americans: Indian pharma
Trump mandates U.S. generic drug production by 2028, imposing escalating tariffs on imports to boost domestic manufacturing.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
- ·
supplychaindive.com
Trump maps out 200% tariffs for generic pharmaceuticals
The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.
- ·
timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
- ·
economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%
Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.
- ·
hindustantimes.com
US to impose steep tariffs on generic medicine imports from Aug 2028
US to impose steep tariffs on generic medicine imports from Aug 2028
- ·
cnbc.com
Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production
The phased schedule is intended to push generic drugmakers to move production onshore.
- ·
thehindubusinessline.com
US to impose 100% tariffs on generic medicine imports from Aug 2028
US President Donald Trump on Wednesday announced steep tariffs on imported generic medicines from August 2028, asserting that the move was aimed at onshoring the manufacturing of…
- ·
france24.com
Trump announces 100% tariffs on imported generic pharmaceutical drugs
US President Donald Trump announced a 100% tariff on imported generic pharmaceutical drugs on Tuesday. The tariff, which aims to bolster US pharmaceutical production, is set to go…
- ·
benzinga.com
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan
Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.
- ·
malaymail.com
Trump imposing 100pc tariff on generic drugs from August 2028
WASHINGTON, July 22 — US President Donald Trump announced yesterday the imposition of steep tariffs on imported generic drugs from August 2028, a move he said was aimed at...
- ·
newsbytesapp.com
Trump threatens tariff on generic medicines: Should India be worried?
US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.
- ·
swissinfo.ch
Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply
(Bloomberg) -- Generic drug manufacturers will have two years to move production to the US or face a 100% import duty from August 2028, President Donald Trump said, threatening…
- ·
0, 100, 200: How Trump's latest generic medicines tariffs could affect India
Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year. | India News
- ·
theprint.in
0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India
US to impose no tariff on generic pharmaceutical goods initially, before hiking to 200%. Announcement set to impact India as US accounts for third of pharma exports from nation.
- ·
Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm
Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufacturing and supply chain strategies. After…
- ·
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?
The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one hundred percent, eventually reaching…
- ·
Trump’s 100% generic drug duty threatens US low-cost supply
President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…
- ·
200% Trump tariff shock? India’s cheap pills may still beat US rivals
US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage…
- ·
Indian pharma firms may yet survive Trump's 200% tariff bombshell
Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say the long-term impact may be limited.…
- ·
Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors
Donald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analysts believe the long-term impact could be…